A Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing strong results, researchers said on Saturday. "(A) recent study carried out by the Gamaleya Centre in Russia showed that revaccination with Sputnik V vaccine is working very well against new coronavirus mutations, including the UK and South African strains of coronavirus," said Denis Logunov, a deputy director of the centre, which developed the Sputnik V shot. The revaccination used the same Sputnik V shot, based upon the same adenovirus vectors. But developers of Sputnik V disagreed this would pose long-term problems. This conclusion was based on a trial of a vaccine against Ebola developed earlier by the Gamaleya Institute using the same approach as for the Sputnik V shot.

Source: Mint February 27, 2021 12:56 UTC